Nurse Practitioner in Puerto Rico Medicare Details, Address, Contact
89 Nurse Practitioner nurses found. Showing 81 - 89
 Brenda Aponte, APRN BC NRS PRACT Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 10 Casia Street, San Juan, PR 00921 Phone: 787-541-7582 |
 Lino Cepeda-acevedo Jr., Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 10 Calle Casia, San Juan, PR 00921 Phone: 787-641-7582 |
Norahyna Ortiz Elias, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 10 Calle Casia, San Juan, PR 00921 Phone: 787-641-7582 |
Nestor Enrique Rodriguez, Nurse Practitioner - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 10 Calle Casia, San Juan, PR 00921 Phone: 787-641-7582 |
Krysia Maria Lago, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: Jardines De San Lorenzo A2 C2, San Lorenzo, PR 00754 Phone: 305-310-7561 |
Marisol Delgado, BSN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Estancia De La Fuente Calle Orquidea #60 H-4, Toa Alta, PR 00953 Phone: 787-667-5919 |
Elia Maria Correa-sierra, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: Pradera Del Rio #154, Rio Cocal St, Toa Alta, PR 00953 Phone: 787-479-7960 |
Irina Villafranca, FNP Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: Hb5 Calle Elisa Tavarez, Toa Baja, PR 00949 Phone: 939-287-4760 |
Lydia Soto, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 593 Calle Madrid, Mansiones De Monterey, Yauco, PR 00698 Phone: 787-543-2471 |
News Archive
Oral BRAF inhibitor can extend survival to 16 months for patients with MM
An international team of researchers from the United States and Australia, including researchers at Moffitt Cancer Center in Tampa, Fla., have found that the oral BRAF inhibitor vemurafenib (PLX4032) when tested in a phase II clinical trial offered a high rate of response in patients with previously treated metastatic melanoma and who had the BRAF mutation.
First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma
Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.
Autologous rib cartilage use in rhinoplasty associated with low rates of overall long-term complications
Using a patient's own rib cartilage (autologous) for rhinoplasty appears to be associated with low rates of overall long-term complications and problems at the rib site where the cartilage is removed, according to a report published online by JAMA Facial Plastic Surgery.
US Department of Commerce honors Cyanotech with Export Achievement Certificate Award
Cyanotech Corporation has received an Export Achievement Certificate Award from the US Department of Commerce. The award is determined by the Hawaii Export Assistance Center of the department. It was presented by Hawaii Governor Linda Lingle, together with John Holman, Director of the Hawaii Export Assistance Center, U.S. Department of Commerce, at the Hawaii State Capitol in Honolulu.
› Verified 2 days ago